Skip to main content

Nabiximols: Multiple Sclerosis

Question for Department of Health and Social Care

UIN HL12144, tabled on 14 January 2021

To ask Her Majesty's Government what assessment they have made about the barriers to prescribing Sativex to treat spasticity in people with multiple sclerosis; and what plans they have to work with NHS England and organisations such as the MS Society to address any such barriers.

Answered on

22 January 2021

The Department has made no recent assessment. However, Departmental officials regularly engage with stakeholders and organisations such as the MS Society, to discuss a range of issues, including concerns relating to access to treatments.